Zent2U

Zent2U is the specialized business-to-business (B2B) division of Zentiva, a leading European pharmaceutical company headquartered in Prague. The entity focuses on the development, manufacturing, and licensing of high-quality generic and value-added medicines for global partners. Its portfolio spans critical therapeutic areas including oncology, cardiovascular health, the central nervous system, and respiratory medicine. Zent2U offers comprehensive contract development and manufacturing organization (CDMO) services, utilizing Zentiva's robust manufacturing network to produce complex oral solids and injectables. By bridging the gap between R&D and commercial supply, Zent2U facilitates the global availability of affordable treatments. The company is backed by the extensive industrial heritage and regulatory expertise of the Zentiva Group.